Ritafee
Is Being Human
So here I am on the 'high' road @Northwind and I have found the high road scripture to aid us all on our journey to the New World Order.
And as it has been ordained for the New World Leader -- So let it be done!
The year is 2023. The COVID-19 pandemic has come to an end, and the global economy is on the path to recovery. How did we get here? How did our economy and society evolve to overcome the greatest crisis of our age?
The U.S. began to change its approach after Nov. 3, 2020, when Joe Biden defeated Donald Trump in the presidential election and the Democrats held the majority in both houses of Congress. Following his Inauguration in January 2021, President Biden moved quickly to rebuild frayed ties between America and Europe, setting up a forum to share collective intelligence that could inform a smarter form of government. European governments were eager to learn from the investment strategies used by the U.S. government—like those led by defense research agency DARPA—to spur research and development in high-risk technologies. And the U.S. was eager to learn from Europe how to create sustainable cities and reinvigorate civic participation.
With COVID-19 still rampant, the world woke up to the need to prioritize collective intelligence and put public value at the center of health innovation. The U.S. and other countries dropped opposition to a mandatory patent pool run by the World Health Organization that prevented pharmaceutical companies from abusing patents to create monopoly profits. Bold conditions were placed on the governance of intellectual property, pricing and manufacturing of COVID-19 treatments and vaccines to ensure the therapies were both affordable and universally accessible.
As a result, pharmaceutical companies could no longer charge whatever they wished for drugs or vaccines; governments made it mandatory for the pricing to reflect the substantial public contribution to their research and development. This extended beyond COVID-19 therapies, impacting the pricing of a range of medicines from cancer therapies to insulin. Richer countries also committed to increasing manufacturing capabilities globally and using mass global procurement to buy vaccines for poorer countries.
On Feb. 11, 2021, the FDA approved the most promising COVID-19 vaccine for manufacture in the U.S. Mass production began immediately, plans for swift global distribution kicked in, and the first citizens received their shots within three weeks, free at the point of use. It was the fastest development and manufacture of a vaccine on record, and a monumental success in health innovation.
When the vaccine was ready for distribution, national health authorities worked constructively with a coalition of global health actors—led by the WHO, the Bill and Melinda Gates Foundation and others—to collectively devise an equitable global distribution plan that supported public-health goals. Low- and middle-income countries, along with health workers and essential workers, were granted priority access to the vaccine, while higher-income countries rolled out immunization programs in parallel.
The end was in sight for our health crisis. But in June 2021, the global economy was still in a depressed state. As governments started debating their options for new stimulus packages, a wave of public protests broke out, with taxpayers in Brazil, Germany, Canada and elsewhere calling for shared rewards in exchange for bailing out corporate giants.
With Biden in office, the U.S. took those demands seriously and attached strong conditions to the next wave of corporate bailouts ...
Want to go higher? ...
time.com
And as it has been ordained for the New World Leader -- So let it be done!
The year is 2023. The COVID-19 pandemic has come to an end, and the global economy is on the path to recovery. How did we get here? How did our economy and society evolve to overcome the greatest crisis of our age?
The U.S. began to change its approach after Nov. 3, 2020, when Joe Biden defeated Donald Trump in the presidential election and the Democrats held the majority in both houses of Congress. Following his Inauguration in January 2021, President Biden moved quickly to rebuild frayed ties between America and Europe, setting up a forum to share collective intelligence that could inform a smarter form of government. European governments were eager to learn from the investment strategies used by the U.S. government—like those led by defense research agency DARPA—to spur research and development in high-risk technologies. And the U.S. was eager to learn from Europe how to create sustainable cities and reinvigorate civic participation.
With COVID-19 still rampant, the world woke up to the need to prioritize collective intelligence and put public value at the center of health innovation. The U.S. and other countries dropped opposition to a mandatory patent pool run by the World Health Organization that prevented pharmaceutical companies from abusing patents to create monopoly profits. Bold conditions were placed on the governance of intellectual property, pricing and manufacturing of COVID-19 treatments and vaccines to ensure the therapies were both affordable and universally accessible.
As a result, pharmaceutical companies could no longer charge whatever they wished for drugs or vaccines; governments made it mandatory for the pricing to reflect the substantial public contribution to their research and development. This extended beyond COVID-19 therapies, impacting the pricing of a range of medicines from cancer therapies to insulin. Richer countries also committed to increasing manufacturing capabilities globally and using mass global procurement to buy vaccines for poorer countries.
On Feb. 11, 2021, the FDA approved the most promising COVID-19 vaccine for manufacture in the U.S. Mass production began immediately, plans for swift global distribution kicked in, and the first citizens received their shots within three weeks, free at the point of use. It was the fastest development and manufacture of a vaccine on record, and a monumental success in health innovation.
When the vaccine was ready for distribution, national health authorities worked constructively with a coalition of global health actors—led by the WHO, the Bill and Melinda Gates Foundation and others—to collectively devise an equitable global distribution plan that supported public-health goals. Low- and middle-income countries, along with health workers and essential workers, were granted priority access to the vaccine, while higher-income countries rolled out immunization programs in parallel.
The end was in sight for our health crisis. But in June 2021, the global economy was still in a depressed state. As governments started debating their options for new stimulus packages, a wave of public protests broke out, with taxpayers in Brazil, Germany, Canada and elsewhere calling for shared rewards in exchange for bailing out corporate giants.
With Biden in office, the U.S. took those demands seriously and attached strong conditions to the next wave of corporate bailouts ...
Want to go higher? ...
It's 2023. Here's How We Fixed the Global Economy
A dispatch from 2023 on how we worked together to build a more sustainable, inclusive economy
time.com
Last edited:
